世界の迅速微生物検査市場2023年~2027年

【英語タイトル】Global Rapid Microbiology Testing Market 2023-2027

Technavioが出版した調査資料(IRTNTR74724-22)・商品コード:IRTNTR74724-22
・発行会社(調査会社):Technavio
・発行日:2022年11月18日
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:北米、アジア、ヨーロッパ、その他地域
・産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥528,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Technavio社の本調査レポートでは、世界の迅速微生物検査市場規模が2023年から2027年の間に2,487.91百万ドル成長すると見込んでおり、予測期間中の年平均成長率は9.31%になると予想しています。本レポートでは、迅速微生物検査の世界市場について広く調査を行い、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、方法別(成長ベース式、核酸ベース式、生存率ベース式、その他)分析、エンドユーザー別(病院・診断研究所、製薬・バイオテクノロジー企業、その他)分析、顧客状況、地域別(北米、アジア、ヨーロッパ、その他地域、アメリカ、中国、ドイツ、イギリス、カナダ)分析、企業分析などを以下の構成でまとめております。本レポートには、Abbott Laboratories、Becton Dickinson and Co.、bioMerieux SA、Biosensia Ltd.、Bruker Corp.、Charles River Laboratories、Colifast AS、Danaher Corp.、Don Whitley Scientific Ltd.、Euroclone SpA、Gradientech ABなどの企業情報が含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界の迅速微生物検査市場規模:方法別
- 成長ベース式迅速微生物検査の市場規模
- 核酸ベース式迅速微生物検査の市場規模
- 生存率ベース式迅速微生物検査の市場規模
- その他の市場規模
・世界の迅速微生物検査市場規模:エンドユーザー別
- 病院・診断研究所における市場規模
- 製薬・バイオテクノロジー企業における市場規模
- その他における市場規模
・地域別状況
- 北米の迅速微生物検査市場規模
- アジアの迅速微生物検査市場規模
- ヨーロッパの迅速微生物検査市場規模
- その他地域の迅速微生物検査市場規模
- アメリカの迅速微生物検査市場規模
- 中国の迅速微生物検査市場規模
- ドイツの迅速微生物検査市場規模
- イギリスの迅速微生物検査市場規模
- カナダの迅速微生物検査市場規模
・成長要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することにより、また複数のソースからのデータを調査、統合、および合計することにより、市場の詳細な全体像を提示します。主要産業のインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。 Technavio社の市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選択方法と分析を提供します。
❖ レポートの概要 ❖

Global Rapid Microbiology Testing Market 2023-2027
Technavio has been monitoring the rapid microbiology testing market and it is poised to grow by $2,487.91 mn during 2023-2027, accelerating at a CAGR of 9.31% during the forecast period. Our report on the rapid microbiology testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of infectious disease and cancer, rise in geriatric population, and the high prevalence of food-borne diseases.

Technavio’s rapid microbiology testing market is segmented as below:

By End-user
• Hospitals and diagnostic laboratories
• Pharmaceutical and biotechnology companies
• Others

By Geographical Landscape
• North America
• Asia
• Europe
• Rest of World (ROW)

This study identifies the rise in food safety concerns as one of the prime reasons driving the rapid microbiology testing market growth during the next few years. Also, advances in technology and the rise in the adoption of microbiology testing for the diagnosis will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the rapid microbiology testing market covers the following areas:
• Rapid microbiology testing market sizing
• Rapid microbiology testing market forecast
• Rapid microbiology testing market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading rapid microbiology testing market vendors that include Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, Biosensia Ltd., Bruker Corp., Charles River Laboratories, Colifast AS, Danaher Corp., Don Whitley Scientific Ltd., Euroclone SpA, Gradientech AB, Merck KGaA, Neogen Corp., Quidel Corp., Rapid Micro Biosystems Inc., rqMicro AG, Sartorius AG, Serosep Ltd., Solus Scientific Ltd., and Thermo Fisher Scientific Inc. Also, the rapid microbiology testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Method
o Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics

• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

• 4 Historic Market Size
o 4.1 Global rapid microbiology testing market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global rapid microbiology testing market 2017 – 2021 ($ million)
o 4.2 Method Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Method Segment 2017 – 2021 ($ million)
o 4.3 End-User Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – End-User Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)

• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027

• 6 Market Segmentation by Method
o 6.1 Market segments
o Exhibit 30: Chart on Method – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Method – Market share 2022-2027 (%)
o 6.2 Comparison by Method
o Exhibit 32: Chart on Comparison by Method
o Exhibit 33: Data Table on Comparison by Method
o 6.3 Growth-based – Market size and forecast 2022-2027
o Exhibit 34: Chart on Growth-based – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Growth-based – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Growth-based – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Growth-based – Year-over-year growth 2022-2027 (%)
o 6.4 Nucleic-acid based – Market size and forecast 2022-2027
o Exhibit 38: Chart on Nucleic-acid based – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Nucleic-acid based – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Nucleic-acid based – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Nucleic-acid based – Year-over-year growth 2022-2027 (%)
o 6.5 Viability-based – Market size and forecast 2022-2027
o Exhibit 42: Chart on Viability-based – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Viability-based – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Viability-based – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Viability-based – Year-over-year growth 2022-2027 (%)
o 6.6 Others – Market size and forecast 2022-2027
o Exhibit 46: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by Method
o Exhibit 50: Market opportunity by Method ($ million)

• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 51: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 52: Data Table on End-user – Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 53: Chart on Comparison by End-user
o Exhibit 54: Data Table on Comparison by End-user
o 7.3 Hospitals and diagnostic laboratories – Market size and forecast 2022-2027
o Exhibit 55: Chart on Hospitals and diagnostic laboratories – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Hospitals and diagnostic laboratories – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Hospitals and diagnostic laboratories – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Hospitals and diagnostic laboratories – Year-over-year growth 2022-2027 (%)
o 7.4 Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027
o Exhibit 59: Chart on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
o 7.5 Others – Market size and forecast 2022-2027
o Exhibit 63: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by End-user
o Exhibit 67: Market opportunity by End-user ($ million)

• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 71: Chart on Geographic comparison
o Exhibit 72: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 73: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Asia – Market size and forecast 2022-2027
o Exhibit 77: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.5 Europe – Market size and forecast 2022-2027
o Exhibit 81: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 85: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 89: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 China – Market size and forecast 2022-2027
o Exhibit 93: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 97: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 UK – Market size and forecast 2022-2027
o Exhibit 101: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.11 Canada – Market size and forecast 2022-2027
o Exhibit 105: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 109: Market opportunity By Geographical Landscape ($ million)

• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 110: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends

• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 112: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 113: Impact of key risks on business

• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 114: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 115: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 116: Abbott Laboratories – Overview
o Exhibit 117: Abbott Laboratories – Business segments
o Exhibit 118: Abbott Laboratories – Key news
o Exhibit 119: Abbott Laboratories – Key offerings
o Exhibit 120: Abbott Laboratories – Segment focus
o 12.4 Becton Dickinson and Co.
o Exhibit 121: Becton Dickinson and Co. – Overview
o Exhibit 122: Becton Dickinson and Co. – Business segments
o Exhibit 123: Becton Dickinson and Co. – Key news
o Exhibit 124: Becton Dickinson and Co. – Key offerings
o Exhibit 125: Becton Dickinson and Co. – Segment focus
o 12.5 bioMerieux SA
o Exhibit 126: bioMerieux SA – Overview
o Exhibit 127: bioMerieux SA – Product / Service
o Exhibit 128: bioMerieux SA – Key offerings
o 12.6 Bruker Corp.
o Exhibit 129: Bruker Corp. – Overview
o Exhibit 130: Bruker Corp. – Business segments
o Exhibit 131: Bruker Corp. – Key news
o Exhibit 132: Bruker Corp. – Key offerings
o Exhibit 133: Bruker Corp. – Segment focus
o 12.7 Charles River Laboratories
o Exhibit 134: Charles River Laboratories – Overview
o Exhibit 135: Charles River Laboratories – Business segments
o Exhibit 136: Charles River Laboratories – Key news
o Exhibit 137: Charles River Laboratories – Key offerings
o Exhibit 138: Charles River Laboratories – Segment focus
o 12.8 Danaher Corp.
o Exhibit 139: Danaher Corp. – Overview
o Exhibit 140: Danaher Corp. – Business segments
o Exhibit 141: Danaher Corp. – Key news
o Exhibit 142: Danaher Corp. – Key offerings
o Exhibit 143: Danaher Corp. – Segment focus
o 12.9 Don Whitley Scientific Ltd.
o Exhibit 144: Don Whitley Scientific Ltd. – Overview
o Exhibit 145: Don Whitley Scientific Ltd. – Product / Service
o Exhibit 146: Don Whitley Scientific Ltd. – Key offerings
o 12.10 Gradientech AB
o Exhibit 147: Gradientech AB – Overview
o Exhibit 148: Gradientech AB – Product / Service
o Exhibit 149: Gradientech AB – Key offerings
o 12.11 Merck KGaA
o Exhibit 150: Merck KGaA – Overview
o Exhibit 151: Merck KGaA – Business segments
o Exhibit 152: Merck KGaA – Key news
o Exhibit 153: Merck KGaA – Key offerings
o Exhibit 154: Merck KGaA – Segment focus
o 12.12 Neogen Corp.
o Exhibit 155: Neogen Corp. – Overview
o Exhibit 156: Neogen Corp. – Business segments
o Exhibit 157: Neogen Corp. – Key news
o Exhibit 158: Neogen Corp. – Key offerings
o Exhibit 159: Neogen Corp. – Segment focus
o 12.13 Quidel Corp.
o Exhibit 160: Quidel Corp. – Overview
o Exhibit 161: Quidel Corp. – Product / Service
o Exhibit 162: Quidel Corp. – Key offerings
o 12.14 Rapid Micro Biosystems Inc.
o Exhibit 163: Rapid Micro Biosystems Inc. – Overview
o Exhibit 164: Rapid Micro Biosystems Inc. – Product / Service
o Exhibit 165: Rapid Micro Biosystems Inc. – Key offerings
o 12.15 rqMicro AG
o Exhibit 166: rqMicro AG – Overview
o Exhibit 167: rqMicro AG – Product / Service
o Exhibit 168: rqMicro AG – Key offerings
o 12.16 Sartorius AG
o Exhibit 169: Sartorius AG – Overview
o Exhibit 170: Sartorius AG – Business segments
o Exhibit 171: Sartorius AG – Key news
o Exhibit 172: Sartorius AG – Key offerings
o Exhibit 173: Sartorius AG – Segment focus
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 174: Thermo Fisher Scientific Inc. – Overview
o Exhibit 175: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 176: Thermo Fisher Scientific Inc. – Key news
o Exhibit 177: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 178: Thermo Fisher Scientific Inc. – Segment focus

• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 179: Inclusions checklist
o Exhibit 180: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 181: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 182: Research methodology
o Exhibit 183: Validation techniques employed for market sizing
o Exhibit 184: Information sources
o 13.5 List of abbreviations
o Exhibit 185: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Method
Exhibits6: Executive Summary – Chart on Market Segmentation by End-user
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global rapid microbiology testing market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Method Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – End-User Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Method – Market share 2022-2027 (%)
Exhibits31: Data Table on Method – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Method
Exhibits33: Data Table on Comparison by Method
Exhibits34: Chart on Growth-based – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Growth-based – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Growth-based – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Growth-based – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Nucleic-acid based – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Nucleic-acid based – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Nucleic-acid based – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Nucleic-acid based – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Viability-based – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Viability-based – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Viability-based – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Viability-based – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Method ($ million)
Exhibits51: Chart on End-user – Market share 2022-2027 (%)
Exhibits52: Data Table on End-user – Market share 2022-2027 (%)
Exhibits53: Chart on Comparison by End-user
Exhibits54: Data Table on Comparison by End-user
Exhibits55: Chart on Hospitals and diagnostic laboratories – Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Hospitals and diagnostic laboratories – Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Hospitals and diagnostic laboratories – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Hospitals and diagnostic laboratories – Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits67: Market opportunity by End-user ($ million)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ million)
Exhibits110: Impact of drivers and challenges in 2022 and 2027
Exhibits111: Overview on Criticality of inputs and Factors of differentiation
Exhibits112: Overview on factors of disruption
Exhibits113: Impact of key risks on business
Exhibits114: Vendors covered
Exhibits115: Matrix on vendor position and classification
Exhibits116: Abbott Laboratories – Overview
Exhibits117: Abbott Laboratories – Business segments
Exhibits118: Abbott Laboratories – Key news
Exhibits119: Abbott Laboratories – Key offerings
Exhibits120: Abbott Laboratories – Segment focus
Exhibits121: Becton Dickinson and Co. – Overview
Exhibits122: Becton Dickinson and Co. – Business segments
Exhibits123: Becton Dickinson and Co. – Key news
Exhibits124: Becton Dickinson and Co. – Key offerings
Exhibits125: Becton Dickinson and Co. – Segment focus
Exhibits126: bioMerieux SA – Overview
Exhibits127: bioMerieux SA – Product / Service
Exhibits128: bioMerieux SA – Key offerings
Exhibits129: Bruker Corp. – Overview
Exhibits130: Bruker Corp. – Business segments
Exhibits131: Bruker Corp. – Key news
Exhibits132: Bruker Corp. – Key offerings
Exhibits133: Bruker Corp. – Segment focus
Exhibits134: Charles River Laboratories – Overview
Exhibits135: Charles River Laboratories – Business segments
Exhibits136: Charles River Laboratories – Key news
Exhibits137: Charles River Laboratories – Key offerings
Exhibits138: Charles River Laboratories – Segment focus
Exhibits139: Danaher Corp. – Overview
Exhibits140: Danaher Corp. – Business segments
Exhibits141: Danaher Corp. – Key news
Exhibits142: Danaher Corp. – Key offerings
Exhibits143: Danaher Corp. – Segment focus
Exhibits144: Don Whitley Scientific Ltd. – Overview
Exhibits145: Don Whitley Scientific Ltd. – Product / Service
Exhibits146: Don Whitley Scientific Ltd. – Key offerings
Exhibits147: Gradientech AB – Overview
Exhibits148: Gradientech AB – Product / Service
Exhibits149: Gradientech AB – Key offerings
Exhibits150: Merck KGaA – Overview
Exhibits151: Merck KGaA – Business segments
Exhibits152: Merck KGaA – Key news
Exhibits153: Merck KGaA – Key offerings
Exhibits154: Merck KGaA – Segment focus
Exhibits155: Neogen Corp. – Overview
Exhibits156: Neogen Corp. – Business segments
Exhibits157: Neogen Corp. – Key news
Exhibits158: Neogen Corp. – Key offerings
Exhibits159: Neogen Corp. – Segment focus
Exhibits160: Quidel Corp. – Overview
Exhibits161: Quidel Corp. – Product / Service
Exhibits162: Quidel Corp. – Key offerings
Exhibits163: Rapid Micro Biosystems Inc. – Overview
Exhibits164: Rapid Micro Biosystems Inc. – Product / Service
Exhibits165: Rapid Micro Biosystems Inc. – Key offerings
Exhibits166: rqMicro AG – Overview
Exhibits167: rqMicro AG – Product / Service
Exhibits168: rqMicro AG – Key offerings
Exhibits169: Sartorius AG – Overview
Exhibits170: Sartorius AG – Business segments
Exhibits171: Sartorius AG – Key news
Exhibits172: Sartorius AG – Key offerings
Exhibits173: Sartorius AG – Segment focus
Exhibits174: Thermo Fisher Scientific Inc. – Overview
Exhibits175: Thermo Fisher Scientific Inc. – Business segments
Exhibits176: Thermo Fisher Scientific Inc. – Key news
Exhibits177: Thermo Fisher Scientific Inc. – Key offerings
Exhibits178: Thermo Fisher Scientific Inc. – Segment focus
Exhibits179: Inclusions checklist
Exhibits180: Exclusions checklist
Exhibits181: Currency conversion rates for US$
Exhibits182: Research methodology
Exhibits183: Validation techniques employed for market sizing
Exhibits184: Information sources
Exhibits185: List of abbreviations



★調査レポート[世界の迅速微生物検査市場2023年~2027年] (コード:IRTNTR74724-22)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の迅速微生物検査市場2023年~2027年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆